Nicole Monroe

Nicole Monroe is a Clinical Research Scientist II at bioMérieux since March 2022, having previously served as a Clinical Affairs Scientist II and I at BioFire Diagnostics, LLC from July 2018 to March 2022, where studies for regulatory clearance of infectious disease molecular diagnostic devices were led. Prior experience includes working as an R&D Scientist at ARUP Laboratories, focusing on next-generation sequencing (NGS) panel development, and a Postdoctoral Fellow at the University of Utah School of Medicine, where the mechanism of substrate translocation by Vps4 AAA ATPase was researched. Nicole also instructed Biological Chemistry Lab courses at the University of Utah College of Science. Educational qualifications include a Dr. sc. nat. in Molecular Life Sciences from the University of Zurich and both a Master of Science and Bachelor of Science in Molecular Biotechnology from the Technical University of Munich.